Literature DB >> 20411309

In vitro dissolution of calcium phosphate-mullite composite in simulated body fluid.

Ashok Priya1, Shekhar Nath, Krishanu Biswas, Bikramjit Basu.   

Abstract

In our recent research, we have developed novel CaP-mullite composites for bone implant applications. In order to realize such applications, the in vitro dissolution behaviour of these materials needs to be evaluated. In this perspective, the present paper reports the dissolution behavior of pure hydroxyapatite (HAp) and hydroxyapatite composites with 20-30 wt% mullite in simulated body fluid (SBF). The in vitro dissolution experiments were carried out for different time duration starting from 7 days up to 28 days. XRD and SEM results show almost no dissolution for pure HAp and HAp composite with 30 wt% mullite. However, HAp-20 wt% mullite composite exhibits considerable dissolution after 7 days. The alpha-TCP phase mainly contributes to the dissolution process. Based on the dynamic changes in pH, ionic conductivity, Ca and P ion concentration in SBF as well as microstructural observations of the bioceramic surfaces after various time frames of immersion in SBF, the differences in dissolution behaviour are discussed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20411309     DOI: 10.1007/s10856-010-4053-1

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  7 in total

1.  In vivo response of novel calcium phosphate-mullite composites: results up to 12 weeks of implantation.

Authors:  Shekhar Nath; Bikramjit Basu; Mira Mohanty; P V Mohanan
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2009-08       Impact factor: 3.368

2.  Initial anchoring and proliferation of fibroblast L-929 cells on unstable surface of calcium phosphate ceramics.

Authors:  T Suzuki; R Ohashi; Y Yokogawa; K Nishizawa; F Nagata; Y Kawamoto; T Kameyama; M Toriyama
Journal:  J Biosci Bioeng       Date:  1999       Impact factor: 2.894

3.  Solutions able to reproduce in vivo surface-structure changes in bioactive glass-ceramic A-W.

Authors:  T Kokubo; H Kushitani; S Sakka; T Kitsugi; T Yamamuro
Journal:  J Biomed Mater Res       Date:  1990-06

4.  Improvement in biocompatibility of ZrO2-Al2O3 nano-composite by addition of HA.

Authors:  Young-Min Kong; Chang-Jun Bae; Su-Hee Lee; Hae-Won Kim; Hyoun-Ee Kim
Journal:  Biomaterials       Date:  2005-02       Impact factor: 12.479

5.  In vitro bioactivity of a biocomposite fabricated from HA and Ti powders by powder metallurgy method.

Authors:  C Q Ning; Y Zhou
Journal:  Biomaterials       Date:  2002-07       Impact factor: 12.479

6.  Ultrastructural comparison of dissolution and apatite precipitation on hydroxyapatite and silicon-substituted hydroxyapatite in vitro and in vivo.

Authors:  Alexandra E Porter; Claudia M Botelho; Maria A Lopes; José D Santos; Serena M Best; William Bonfield
Journal:  J Biomed Mater Res A       Date:  2004-06-15       Impact factor: 4.396

7.  Activity of plasma sprayed yttria stabilized zirconia reinforced hydroxyapatite/Ti-6Al-4V composite coatings in simulated body fluid.

Authors:  Y W Gu; K A Khor; D Pan; P Cheang
Journal:  Biomaterials       Date:  2004-07       Impact factor: 12.479

  7 in total
  2 in total

1.  An X-ray micro-fluorescence study to investigate the distribution of Al, Si, P and Ca ions in the surrounding soft tissue after implantation of a calcium phosphate-mullite ceramic composite in a rabbit animal model.

Authors:  Richard A Martin; Zahira Jaffer; Garima Tripathi; Shekhar Nath; Mira Mohanty; Victoria Fitzgerald; Pierre Lagarde; Anne-Marie Flank; Artemis Stamboulis; Bikramjit Basu
Journal:  J Mater Sci Mater Med       Date:  2011-08-30       Impact factor: 3.896

2.  Dentin-Derived Inorganic Minerals Promote the Osteogenesis of Bone Marrow-Derived Mesenchymal Stem Cells: Potential Applications for Bone Regeneration.

Authors:  Gang Lei; Yanqiu Wang; Yan Yu; Zehan Li; Jiamin Lu; Xingyun Ge; Na Li; Ana Gloria Cuba Manduca; Jinhua Yu
Journal:  Stem Cells Int       Date:  2020-11-19       Impact factor: 5.443

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.